Pediatric Empyema in the Post-Pandemic Period: Evaluating Changing Trends in Microbiology, Investigations, Fibrinolysis, and Surgical Outcomes
Topic overview
This retrospective study examines shifts in pediatric empyema management over 8 years, including the 2022-2023 UK invasive group A Streptococcus surge. The analysis evaluates changes in microbial patterns, diagnostic approaches, fibrinolytic therapy, and surgical outcomes in the post-pandemic era.
Key takeaways
- Post-pandemic UK saw surge in invasive group A Streptococcus empyema cases during 2022-2023
- 8-year retrospective reveals shifting microbial patterns in pediatric empyema requiring updated treatment protocols
- Study compares fibrinolytic therapy vs surgical outcomes across pre- and post-pandemic cohorts
- Changing disease patterns suggest need to reassess empiric antibiotic coverage for pediatric empyema
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Pediatric Empyema in the Post-Pandemic Period: Evaluating Changing Trends in Microbiology, Investigations, Fibrinolysis, and Surgical Outcomes. GlobalCastMD Medical Library. 2025-12-26. https://library.globalcastmd.com/article/11346
Comments